Context Therapeutics Inc. (CNTX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Context Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$0.21
−9.97% today
Market cap
$22M
Overall quality
55/100
Kronos AI 30-day
—
Context Therapeutics Inc. (CNTX) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $22M. It trades at $0.21, down 9.97% today. Its overall quality score is 55 out of 100, ranked against the whole US market. 7 analysts' average target of $3.50 implies +1566.7% from today's price.
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $3.50 |
| Low – high | $2.00 – $5.00 |
| Analysts | 7 |
| Upside to average | +1566.7% |
Kronos AI 30-day forecast
No forecast for this listing.
Quality scores
| Profitability | 39 |
| Solvency | 93 |
| Growth | 32 |
| Overall | 55 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.